Imidazolidin-4-one derivatives useful as anticancer agents
US6080769A · kind A · utility
9Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 28, 1998 |
| Grant date | Jun 27, 2000 |
| Priority date | — |
| Expiry date | Dec 28, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D249/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula 1 ##STR1## and to pharmaceutically acceptable salts and solvates thereof, wherein Z, R, R.sup.3 and R.sup.4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of inhibiting abnormal cell growth, including cancer, in a mammal by administering the compounds of formula 1 to said mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.